Kopechek, Jonathan A.;
Chrzanowski, Stephen M.;
Smith, Denise A. B.;
Gaskins, Whitney B.;
Abruzzo, Todd A.;
Huang, Shaoling L.;
McPherson, David D.;
Holland, Christy K.
Ultrasound-mediated release of calcein from echogenic liposomes
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Ultrasound-mediated release of calcein from echogenic liposomes
Beteiligte:
Kopechek, Jonathan A.;
Chrzanowski, Stephen M.;
Smith, Denise A. B.;
Gaskins, Whitney B.;
Abruzzo, Todd A.;
Huang, Shaoling L.;
McPherson, David D.;
Holland, Christy K.
Erschienen:
Acoustical Society of America (ASA), 2007
Erschienen in:The Journal of the Acoustical Society of America
Beschreibung:
<jats:p>Echogenic liposomes (ELIP) have been developed for drug encapsulation. The gas contents in ELIP present a potential mechanism for ultrasound-triggered release of drug contents. Calcein, a fluorescent dye, was loaded in ELIP as a drug substitute (C-ELIP) and ultrasound-induced release was quantified with fluorescence spectrophotometry. Pulsed 6.0-MHz color Doppler from a clinical diagnostic ultrasound scanner (CL15-7 transducer, Philips HDI 5000, MI of 1.3, 150 Hz pulse repetition frequency) was applied to samples of C-ELIP in an in vitro flow phantom (2.2 ml/min). For comparison, Triton X-100 was added to C-ELIP to release calcein. Control samples of C-ELIP were not treated with ultrasound or Triton X-100. The echogenicity of C-ELIP (expressed as mean digital intensity in a 0.5 cm2 region of interest) decreased by 9.6±2.1 dB after exposure to ultrasound. The observed calcein concentration (μg/ml) was 3.1±0.1 for the untreated sample, 4.5±0.1 after Triton X-100 treatment, and 4.2±0.2 after ultrasound exposure. 65.6% of encapsulated calcein was released with ultrasound. These results demonstrate that ultrasound-mediated release of drugs from ELIP using a clinical diagnostic ultrasound scanner is feasible. [Work supported by an AIUM Education and Research Grant and NIH 1R01 HL074002, and NIH 1RO1 NS047603-01S1.]</jats:p>